MRI and body biomarkers study for muscular dystrophy
Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital clinical trials.
This study uses MRI scans and blood or other biomarkers to better understand muscular dystrophy in people with Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD). It may help researchers track disease changes and identify measurable markers over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re a male with Duchenne or Becker muscular dystrophy (DMD or BMD)
- Your age fits the study group: DMD ages 5–30, BMD ages 18–62
- You can safely have an MRI scan (no MRI-incompatible metal or devices)
- You can cooperate during scans and testing (able to follow directions)
- You don’t have a serious unstable health problem or other conditions that strongly affect muscle metabolism/function
- You don’t use daytime ventilation, and you don’t have an implanted pacemaker or ICD
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a new type of ultrasound scan to look at muscle health in people with Duchenne or Becker muscular dystrophy. It aims to find better ways to track the disease over time.
This study uses brain and muscle scans, thinking tests, and muscle assessments to understand how the absence of the Dp140 protein affects people with Becker muscular dystrophy. You may be able to join if you have this condition, can walk, and are interested in helping doctors learn more.
This study looks for signals in blood and other body fluids that may help track Duchenne or Becker muscular dystrophy. It may be helpful for patients by improving how future monitoring tests are developed.
This study collects blood and, for some people, muscle tissue to look for signs (biomarkers) that can help track and better understand myotonic dystrophy. You may help by providing samples and basic muscle function testing, depending on your age and condition type.
This study follows women who have a confirmed DMD gene mutation (a genetic change related to Duchenne/Becker muscular dystrophy) to learn more about health and muscle-related measurements. Depending on the part of the study, you may be asked to take part in MRI or other assessments.
This study follows boys with Duchenne muscular dystrophy over time to better understand how the condition changes and how standard treatments affect health and function. It does not appear to test a new medicine, but it may help doctors plan better future care and studies.
Hear when a new Duchenne Muscular Dystrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.